Tina M. Albertson

Chief Medical Officer, Lyell Immunopharma, Inc.

Companies

Caribou Biosciences, Inc.Chief Medical Officer Aug 20, 2024 to now¹
Lyell Immunopharma, Inc.Chief Medical Officer Mar 29, 2022 to Feb 28, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lyell Immunopharma, Inc. LYEL4,049 shares³$35.5K at $8.77Feb 28, 2023
Caribou Biosciences, Inc. CRBU68,523 shares⁴$31.5K at $0.46Feb 24, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 24, 2026Sold 1,066 shares at $1.96 of Caribou Biosciences, Inc.⁴
Feb 20, 2026Granted 55,000 shares of Caribou Biosciences, Inc.⁴
Feb 20, 2025Granted 14,589 shares of Caribou Biosciences, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCaribou Biosciences, Inc., Chief Medical Officer
2
SEC EDGARLyell Immunopharma, Inc., Chief Medical Officer
3
SEC EDGARLyell Immunopharma, Inc. shares after the filing of Feb 28, 2023
4
SEC EDGARCaribou Biosciences, Inc. shares after the filing of Feb 24, 2026
5
SEC EDGARForm 4 filed Feb 21, 2025